Clinical Trial Details
— Status: Completed
Administrative data
| NCT number |
NCT01880541 |
| Other study ID # |
IB2009-71 |
| Secondary ID |
|
| Status |
Completed |
| Phase |
N/A
|
| First received |
|
| Last updated |
|
| Start date |
December 2010 |
| Est. completion date |
December 2017 |
Study information
| Verified date |
December 2021 |
| Source |
Institut Bergonié |
| Contact |
n/a |
| Is FDA regulated |
No |
| Health authority |
|
| Study type |
Interventional
|
Clinical Trial Summary
The emergence of cognitive disorders after surgery under general anesthesia (GA) is the
second leading cause of patient complaints (after dental debris caused by intubation
techniques). These cognitive disorders can range from simple reversible confusion (26%) with
postoperative cognitive dysfunction without actual recovery (10%).
The hypnosedation is an ancient technique of anesthesia expanding its effects on cognitive
function remain to this day unknown, but appear promising.
Description:
For twenty years, hypnosedation is offered to patients who underwent surgery as an
alternative to other anesthetic techniques (general anesthesia and locoregional), in some
European and Anglo-Saxon hospitals for specific surgical indications (surgery area). It is
commonly used in some hospitals.
The hypnosedation is little used in oncology
The hypnosedation is a hypnosis technique suitable for anesthesia, namely the one associated
with intravenous conscious sedation and local anesthesia hypnosis. This derived from medical
hypnosis Ericksoniene technique is divided into three stages:
1. induction
2. Deepening trance
3. Déhypnotisation.
This technique is currently being validated and used at national and international level, in
fact it is based on 500 references and appears in the national nomenclature of the Common
Classification of Medical Procedures in the code ANRP 001, states: hypnosis referred to
analgesic.
